comparemela.com

Latest Breaking News On - Heloisa soares - Page 1 : comparemela.com

New Trial Tests Chemotherapy Regimen Following Pancreatic Cancer Surgery

A new clinical trial is testing the effectiveness of chemotherapy treatment following surgery for a subset of pancreatic cancer patients.

Heloisa soaresUniversity of cincinnati cancer centerOncology groupCancer research networkUniversity of cincinnati syed ahmadUniversity of utahUc college of medicineSyed ahmadCincinnati cancer centerResearch network

Clinical trial tests effectiveness of chemotherapy after surgery for pancreatic neuroendocrine tumors

A new clinical trial is testing the effectiveness of chemotherapy treatment following surgery for a subset of pancreatic cancer patients.

Lily ramseySyed ahmadHeloisa soaresOncology groupUniversity of utahCancer research networkUc college of medicineUniversity of cincinnati syed ahmadUniversity of cincinnati cancer centerCincinnati cancer centerResearch networkPancreatic cancerClinical trial

Investegate |ITM Isotope Technologies Munic Announcements | ITM Isotope Technologies Munic: ITM to Present Phase III COMPOSE Poster and Host Satellite Symposium on Radiotheranostics in NET cancer at ENETS Conference

Investegate announcements from ITM Isotope Technologies Munic, ITM to Present Phase III COMPOSE Poster and Host Satellite Symposium on Radiotheranostics in NET cancer at ENETS Conference

United statesUppsala lanComunidad autonoma de catalunaJaume capdevilaBen orzelekJulia hofmann svenjaWolfgang weberAldo scarpaHeloisa soaresUppsala universityHospital trust of veronaHebron university hospitalUniversity of utahEuropean neuroendocrine tumor societyTechnical university of munichCorporate communications

ITM to Present Phase III COMPOSE Poster and Host Satellite

Garching / Munich, March 16, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical theranostics company, today announced that the.

United statesUppsala lanComunidad autonoma de catalunaJaume capdevilaBen orzelekJulia hofmann svenjaWolfgang weberAldo scarpaHeloisa soaresUppsala universityHospital trust of veronaHebron university hospitalUniversity of utahEuropean neuroendocrine tumor societyTechnical university of munichCorporate communications

ITM Isotope Technologies Munich SE: ITM to Present Phase III COMPOSE Poster and Host Satellite Symposium on Radiotheranostics in NET cancer at ENETS Conference

Garching / Munich, March 16, 2023 - ITM Isotope Technologies Munich SE) in a poster presentation at the 20th Annual European Neuroendocrine Tumor Society(n.c.a. 177Lu-edotreotide) compared to standard

United statesUppsala lanComunidad autonoma de catalunaDennis riedlJaume capdevilaBen orzelekJulia hofmann svenjaWolfgang weberAldo scarpaHeloisa soaresUppsala universityHospital trust of veronaHebron university hospitalUniversity of utahEuropean neuroendocrine tumor societyTechnical university of munich

vimarsana © 2020. All Rights Reserved.